Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HPE 101

Known as: HPE-101 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
We evaluated a needle-free injector (NFI), which has been studied as an administration device to the subcutaneous tissue, as a… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
Phenserine (PS) was designed as a selective acetylcholinesterase (AChE) inhibitor, with a tartrate form (PST) for oral… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2006
2006
The influence of skin permeation enhancers, such as dimethyl sulphoxide (DMSO) and 1-[2-(decylthio)ethyl]azacyclopentan-2-one… Expand
  • figure 1
Is this relevant?
2004
2004
Microdialysis was applied to determine the in vivo transdermal absorption of methotrexate (MTX) in rats with or without a new… Expand
Is this relevant?
1996
1996
The purpose of this study was to evaluate the effect of absorption enhancer on in‐vivo transdermal absorption of cyclosporin… Expand
Is this relevant?
1994
1994
The suitability of sampling via microdialysis for a lipophilic drug, valproate (VPA), was evaluated by the elimination rate… Expand
Is this relevant?
1993
1993
Abstract— The penetration enhancer, 1‐[2‐(decylthio)ethyl]azacyclopentan‐2‐one (HPE‐101), significantly enhanced the excretion of… Expand
Is this relevant?
1992
1992
A new compound, 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101) was synthesized, and its skin penetration enhancing activity… Expand
Is this relevant?
1992
1992
Prostaglandin E1 (PGE1) and its inclusion complexes with beta-cyclodextrin (beta-CyD) and O-carboxymethyl-O-ethyl-beta… Expand
Is this relevant?
1992
1992
Abstract— The optimal prescription of transdermal preparations of prostaglandin E1 (PGE1) for treatment of peripheral vascular… Expand
Is this relevant?